Brokerage Firm Rating Update on Varian Medical Systems (VAR)

Varian Medical Systems (VAR) has an average broker rating of 2.06, which is interpreted as a Buy, as rated by 5 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 1 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 1 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company.

Varian Medical Systems (VAR) : The highest short term price target forecast on Varian Medical Systems (VAR) is $102 and the lowest target price is $86. A total of 5 equity analysts are currently covering the company. The average price of all the analysts is $93.4 with a standard deviation of $6.47.


Company shares have received an average consensus rating of Hold for the current week Also, In the latest statement by the brokerage house, Citigroup maintains its outlook on Varian Medical Systems (NYSE:VAR). The current rating of the shares is Neutral, according to the research report released by the firm. The brokerage firm raises the price target from $84 per share to $88 per share. The rating by the firm was issued on July 28, 2016.

Varian Medical Systems (NYSE:VAR): The stock opened at $96.33 and touched an intraday high of $97.45 on Wednesday. During the day, the stock corrected to an intraday low of $96.065, however, the bulls stepped in and pushed the price higher to close in the green at $97.27 with a gain of 0.81% for the day. The total traded volume for the day was 562,514. The stock had closed at $96.49 in the previous trading session.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.